This bill amends Chapter 17, Title 54 of the Idaho Code by adding a new section, 54-1740, which establishes provisions aimed at ensuring affordable access to prescription drugs, specifically those classified as 340B drugs. The bill defines key terms such as "340B drug," "contract pharmacy," "covered entity," and "pharmaceutical manufacturer." It prohibits pharmaceutical manufacturers from denying or interfering with the acquisition and delivery of 340B drugs to contract pharmacies on behalf of covered entities. Additionally, it restricts manufacturers from imposing conditions on covered entities or contract pharmacies regarding the submission of claims or data related to 340B drugs, except for specific compliance audits.

The bill also clarifies that its provisions are intended to be consistent with federal law and that they will not be less restrictive than applicable federal regulations. It includes a severability clause, ensuring that if any part of the section is deemed invalid, the remaining provisions will still stand. Furthermore, the bill states that if the federal 340B drug pricing program is eliminated, the provisions of this section will become null and void. An emergency clause is included, making the act effective on July 1, 2025.